Add office photos
Employer?
Claim Account for FREE
Novo Nordisk
4.1
based on 896 Reviews
Proud winner of ABECA 2024 - AmbitionBox Employee Choice Awards
Company Overview
Company Locations
Working at Novo Nordisk
Company Summary
Novo Nordisk is one of the leading global healthcare company, founded in 1923 and headquartered in Denmark. Their purpose is to drive change to defeat diabetes and other serious chronic diseases.
Overall Rating
4.1/5
based on 896 reviews
16% above
industry average
Highly rated for
Job Security, Work-Life Balance, Company Culture
Work Policy
Hybrid
79% employees reported
Monday to Friday
63% employees reported
Flexible timing
75% employees reported
No travel
38% employees reported
View detailed work policy
Top Employees Benefits
Health insurance
94 employees reported
Job/Soft skill training
81 employees reported
Cafeteria
45 employees reported
International/On-site exposure
35 employees reported
View all benefits
About Novo Nordisk
Founded in1923 (101 yrs old)
India Employee Count1k-5k
Global Employee Count10k-50k
HeadquartersNew York City,New York, United States
Office Locations
--
Websitenovonordisk.com
Primary Industry
Other Industries
Are you managing Novo Nordisk's employer brand? To edit company information,
claim this page for free
At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic diseases.
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 42,200 people in 80 countries and markets its products in more than 170 countries.
Managing your company's employer brand?
Claim this Company Page for FREE
Report error
AmbitionBox Best Places to Work in India Awards
Best of the best, rated by employees
Novo Nordisk won India’s Largest Employee Choice Awards in Mid-Sized Companies Category.
#3 Top Rated Pharma Company
Share
Novo Nordisk Ratings
based on 896 reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
441
4
232
3
104
2
42
1
77
Category Ratings
4.0
Job Security
4.0
Work-Life Balance
4.0
Company Culture
3.9
Skill Development
3.8
Salary & Benefits
3.8
Work Satisfaction
3.4
Promotions/Appraisal
Novo Nordisk is rated 4.1 out of 5 stars on AmbitionBox, based on 896 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Novo Nordisk
based on 848 reviews
4.2
Rated by 249 Women
Rated 4.2 for Job Security and 4.2 for Company Culture
4.1
Rated by 599 Men
Rated 4.0 for Job Security and 4.0 for Work-Life Balance
Work Policy at Novo Nordisk
based on 82 reviews in last 6 months
Hybrid
79%
Work from office
21%
Novo Nordisk Reviews
Top mentions in Novo Nordisk Reviews
+ 5 more
Compare Novo Nordisk with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 896 reviews | 4.1/5 based on 1.8k reviews | 4.3/5 based on 1.1k reviews | 4.0/5 based on 390 reviews |
Highly Rated for | Job Security Work-Life balance Company culture | Company culture Salary & Benefits Skill development | Work-Life balance Company culture Skill development | Work-Life balance Job Security Company culture |
Critically Rated for | No critically rated category | No critically rated category | No critically rated category | Promotion/Appraisals |
Primary Work Policy | Hybrid 79% employees reported | Hybrid 63% employees reported | Hybrid 58% employees reported | Hybrid 89% employees reported |
Rating by Women Employees | 4.2 Good rated by 249 women | 4.1 Good rated by 262 women | 4.3 Good rated by 208 women | 4.1 Good rated by 100 women |
Rating by Men Employees | 4.1 Good rated by 599 men | 4.1 Good rated by 1.4k men | 4.3 Good rated by 862 men | 4.0 Good rated by 261 men |
Job Security | 4.0 Good | 3.8 Good | 4.0 Good | 4.0 Good |
View more
Novo Nordisk Salaries
3.8
rated by 896 employees for salariesBusiness Analyst
(335 salaries)
Unlock
₹6.5 L/yr - ₹22 L/yr
Senior Product Specialist
(202 salaries)
Unlock
₹4.2 L/yr - ₹10.1 L/yr
Product Specialist
(186 salaries)
Unlock
₹3 L/yr - ₹8.5 L/yr
Advanced Business Analyst
(172 salaries)
Unlock
₹10.9 L/yr - ₹30 L/yr
Associate Business Analyst
(162 salaries)
Unlock
₹6 L/yr - ₹18 L/yr
Key Account Manager
(121 salaries)
Unlock
₹5.2 L/yr - ₹13.7 L/yr
Project Manager
(64 salaries)
Unlock
₹9.2 L/yr - ₹32 L/yr
Senior Associate
(63 salaries)
Unlock
₹5.6 L/yr - ₹12 L/yr
Drug Safety Associate
(62 salaries)
Unlock
₹3.5 L/yr - ₹7 L/yr
Area Sales Manager
(52 salaries)
Unlock
₹9.3 L/yr - ₹19 L/yr
Novo Nordisk Interview Questions
Interview questions by designation
Top Novo Nordisk interview questions and answers
Get interview-ready with top interview questions
Interview Process at Novo Nordisk
based on 26 interviews in last 1 year
Interview Experience
3.7
Good
Difficulty level
Easy
18%
Moderate
82%
People are getting interviews through
based on 59 Novo Nordisk interviews
Job Portal
38%
Referral
17%
Company Website
17%
Recruitment Consultant
5%
*23% candidates got the interview through other sources
High confidence
Novo Nordisk Jobs
Novo Nordisk News
View all
Stocks on Sale: Novo Nordisk, Viking Therapeutics, Nike, and Bitcoin
- Novo Nordisk (NVO) faced a significant drop in value due to overreaction to Eli Lilly's clinical data
- Novo reported Phase 3 results of its weight loss therapy, but investors are concerned about competition
- Nike (NKE) closed at $77.00 after second-quarter results, focusing on digital channels and reducing excess inventory
- Bitcoin (BTC-USD) dropped to around $97,290 due to the Fed's indication of fewer interest rate cuts in 2025
Baystreet | 23 Dec, 2024
Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints
- Novo Nordisk's stock tanked after a highly anticipated drug trial disappointed.
- The study showed its new obesity drug helped people lose less weight than expected.
- Eli Lilly, a competitor in the market for GLP-1 weight loss drugs, was up about 5%.
- Novo Nordisk's stock suffered its biggest one-day slide on record after its latest obesity drug trial disappointed investors.
Insider | 20 Dec, 2024
Novo Nordisk Falls on Trial Results
- Shares of Novo Nordisk fell after results of a late-stage trial for its weight loss drug missed expectations.
- The experimental drug, CagriSema, helped patients reduce weight by 22.7%, below the 25% forecasted.
- Novo Nordisk's stock dropped around 18.8% in London trading.
- The trial results are a setback for the potential of CagriSema to become a next-generation obesity drug.
Baystreet | 20 Dec, 2024
Novo Nordisk Invests $1.2 Billion In Drugs To Treat Rare Diseases
- Danish drugmaker Novo Nordisk is investing $1.2 billion in a new facility to produce medications for rare diseases.
- The facility will be based in Odense, Denmark and will manufacture medications to treat conditions like haemophilia.
- Construction has already begun and is expected to be completed in 2027, creating 400 permanent jobs.
- Novo Nordisk has announced other significant investments, including building a facility in the US and the stock has risen 5% this year.
Baystreet | 16 Dec, 2024
Eli Lilly Strengthens on Favourable Drug Tests
- Eli Lilly's obesity drug Zepbound resulted in more weight loss than Novo Nordisk's Wegovy in a head-to-head clinical trial.
- Zepbound helped patients lose an average of 20.2% of their body weight after 72 weeks, while Wegovy resulted in a 13.7% weight loss in the same period.
- Zepbound showed a 47% higher relative weight reduction compared to Wegovy in the trial.
- Multiple studies consistently suggest that Zepbound performs better in terms of weight loss compared to Wegovy.
Baystreet | 4 Dec, 2024
Biotech Startup Cradle Raises $73 Million to Boost Protein Engineering
- Amsterdam-based biotech startup Cradle has raised $73 million in Series B funding to support its AI-powered platform for protein engineering.
- Cradle uses generative AI to design and engineer proteins, including enzymes, vaccines, peptides, and antibodies, in a more efficient and cost-effective manner.
- The latest investment will help Cradle address challenges in therapeutics, diagnostics, food, chemicals, and agriculture industries, with companies like Novo Nordisk and Johnson & Johnson already using their platform.
- Cradle's generative protein language model, trained on billions of sequences, significantly reduces the number of experimental rounds needed for protein development, leading to faster results and increased project success rates.
Analyticsindiamag | 26 Nov, 2024
Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says
- Shares of obesity drug makers have tumbled since the appointment of RFK Jr. to lead HHS, but analysts at BMO Capital Markets believe the sell-off was overdone.
- Kennedy's critical stance on weight loss drugs may impact pricing or Medicare coverage, but analysts argue that his role has limited ability to change policies related to the drugs.
- The head of HHS is typically an administrative position, and Kennedy's ability to influence GLP-1 drug pricing or the passage of bills is limited.
- Analysts maintain that weight loss drugs still have massive potential, citing Novo Nordisk's recent launch in China and the untapped market of around 180 million obese adults.
Insider | 20 Nov, 2024
Novo Nordisk sells hit weight-loss drug in China—at fraction of US price
- Novo Nordisk is selling its weight-loss drug Wegovy in China for 1,400 yuan, or $193, which is significantly lower than the US price of $1,349.
- The Chinese price is consistent with prices in other countries outside of the US, such as Canada, Denmark, Germany, and the UK.
- During a Senate hearing, Novo Nordisk CEO Lars Jørgensen faced criticism for the high prices of Wegovy and Ozempic, another popular drug for diabetes.
- The issue of high drug prices in the US was described as a profound moral issue by Senator Bernie Sanders.
Arstechnica | 20 Nov, 2024
Novo Nordisk’s Stock Rises As Weight Loss Drug Sales Accelerate
- Novo Nordisk's stock rose by 8% in European trading following the company's strong sales of weight loss medications.
- The pharmaceutical company's third-quarter sales were slightly below expectations at 71.3 billion Danish crowns ($10.3 billion U.S).
- However, sales of Novo Nordisk's weight loss and diabetes medications, including Ozempic and Wegovy, exceeded expectations.
- Novo Nordisk has become Europe's most valuable publicly traded company due to the rising demand for its diabetes and obesity drugs.
Baystreet | 6 Nov, 2024
Powered by
Novo Nordisk Offices
Compare Novo Nordisk with
Abbott
4.2
Pfizer
4.0
Merck
4.2
Johnson & Johnson
4.1
AstraZeneca
4.1
Bayer
4.1
Roche Holding
5.0
Aurobindo Pharma
4.0
Viatris
4.2
Akums Drugs & Pharmaceuticals Limited
4.4
DIVI'S Laboratories
3.8
Fresenius Kabi
4.2
Piramal Pharma
4.0
Thermo Fisher Scientific
3.9
GlaxoSmithKline Consumer Healthcare
4.3
Sandoz
4.0
Par Pharmaceutical Companies
4.3
Novartis Healthcare
4.1
Apex Laboratories
4.0
Agilent Technologies
4.2
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Novo Nordisk
Eli Lilly and Company
Pharma
4.0
• 390 reviews
Sanofi
Biotech & Life sciences, Manufacturing, Analytics & KPO, Pharma
4.3
• 1.1k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 1.8k reviews
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.2
• 2.9k reviews
Johnson & Johnson
Manufacturing
4.1
• 1.3k reviews
AstraZeneca
Biotechnology, Pharma
4.1
• 785 reviews
Bayer
Agriculture, Chemicals / Agri Inputs, Pharma, Chemicals, Agro Chemicals
4.1
• 699 reviews
5.0
• 1 reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.6k reviews
Viatris
Manufacturing, Pharma
4.2
• 3k reviews
Novo Nordisk FAQs
When was Novo Nordisk founded?
Where is the Novo Nordisk headquarters located?
How many employees does Novo Nordisk have in India?
Does Novo Nordisk have good work-life balance?
Is Novo Nordisk good for career growth?
What are the pros of working in Novo Nordisk?
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
